Smart Blood Culture Bottle Trial: Electrochemical Profiling and Machine Learning Target Earlier Pathogen ID in Bacteraemia — What Clinicians Need to Know
247 Health News Editorial
·23 July 2026
·5 min read
·clinical-trialsA novel clinical study at the University Hospital of Grenoble is building an electrochemical signature database of bloodstream pathogens growing within standard blood culture bottles, with the goal of training machine learning models to identify organisms before conventional positivity signals are detected. The research targets one of the most persistent bottlenecks in sepsis management — the diagnostic void between blood collection and actionable microbiological results. Infectious disease physicians, intensivists, and clinical microbiologists should follow this translational programme closely.
Originally reported by ClinicalTrials.gov
References
- 1.University Hospital, Grenoble. (2025). Towards a smart blood culture bottle: Machine learning assisted electrochemical profiling to provide early in-situ identification of bloodstream infections pathogens (NCT06853301). ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT06853301
- 2.Idelevich, E. A., & Becker, K. (2019). How to accelerate antimicrobial susceptibility testing. Clinical Microbiology and Infection, 25(11), 1347–1355. https://doi.org/10.1016/j.cmi.2019.04.025
- 3.Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., Schorr, C., Simpson, S., Wiersinga, W. J., Alshamsi, F., Angus, D. C., Arabi, Y., Azevedo, L., Beale, R., Beilman, G., … Dellinger, R. P. (2021). Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock 2021. Intensive Care Medicine, 47(11), 1181–1247. https://doi.org/10.1007/s00134-021-06506-y
- 4.Kadri, S. S., Lai, Y. L., Warner, S., Strich, J. R., Babiker, A., Ricotta, E. E., Demirkale, C. Y., Dekker, J. P., Palmore, T. N., Rhee, C., & Klompas, M. (2021). Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: A retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. The Lancet Infectious Diseases, 21(2), 241–251. https://doi.org/10.1016/S1473-3099(20)30477-1
- 5.Goto, M., & Al-Hasan, M. N. (2013). Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clinical Microbiology and Infection, 19(6), 501–509. https://doi.org/10.1111/1469-0691.12195
- 6.Peker, N., Couto, N., Sinha, B., & Rossen, J. W. (2018). Diagnosis of bloodstream infections from positive blood cultures and directly from blood samples: Recent developments in molecular approaches. Clinical Microbiology and Infection, 24(9), 944–955. https://doi.org/10.1016/j.cmi.2018.02.024
2
247 Health News Editorial
247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.
Related Articles
clinical-trials
Digital Health Platform vs Case Manager Support in Hypertension Management: Taiwan's 1,726-Participant Trial Signals a Shift in Blood Pressure Care Delivery
3 Aug 2026
clinical-trials
Phase II Trial: AI-Powered Wysa Chatbot vs Unmet Need — Digital Eating Disorder Prevention in At-Risk Adolescents
3 Aug 2026
clinical-trials
Pilot Trial Targets the Inpatient-to-Outpatient Gap: Digital Smoking Cessation Intervention for Persons With Serious Mental Illness — Key Findings for Clinicians
3 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service